Literature DB >> 21356479

Functional and molecular image guidance in radiotherapy treatment planning optimization.

Shiva K Das1, Randall K Ten Haken.   

Abstract

Functional and molecular imaging techniques are increasingly being developed and used to quantitatively map the spatial distribution of parameters, such as metabolism, proliferation, hypoxia, perfusion, and ventilation, onto anatomically imaged normal organs and tumor. In radiotherapy optimization, these imaging modalities offer the promise of increased dose sparing to high-functioning subregions of normal organs or dose escalation to selected subregions of the tumor as well as the potential to adapt radiotherapy to functional changes that occur during the course of treatment. The practical use of functional/molecular imaging in radiotherapy optimization must take into cautious consideration several factors whose influences are still not clearly quantified or well understood including patient positioning differences between the planning computed tomography and functional/molecular imaging sessions, image reconstruction parameters and techniques, image registration, target/normal organ functional segmentation, the relationship governing the dose escalation/sparing warranted by the functional/molecular image intensity map, and radiotherapy-induced changes in the image intensity map over the course of treatment. The clinical benefit of functional/molecular image guidance in the form of improved local control or decreased normal organ toxicity has yet to be shown and awaits prospective clinical trials addressing this issue.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21356479      PMCID: PMC3062208          DOI: 10.1016/j.semradonc.2010.10.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  82 in total

Review 1.  Metabolic functional imaging for tumor radiosensitivity monitoring.

Authors:  Yazid Belkacémi; Pelagia Tsoutsou; Nicolas Magné; Pierre Castadot; David Azria
Journal:  Crit Rev Oncol Hematol       Date:  2007-01-22       Impact factor: 6.312

2.  Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions.

Authors:  Markus Rudin
Journal:  Eur Radiol       Date:  2007-03-06       Impact factor: 5.315

3.  On the impact of functional imaging accuracy on selective boosting IMRT.

Authors:  Y Kim; W A Tomé
Journal:  Phys Med       Date:  2008-01-18       Impact factor: 2.685

4.  Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

Authors:  Piet Dirix; Vincent Vandecaveye; Frederik De Keyzer; Sigrid Stroobants; Robert Hermans; Sandra Nuyts
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

Review 5.  Adaptive radiotherapy for lung cancer.

Authors:  Jan-Jakob Sonke; José Belderbos
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

6.  Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters.

Authors:  Yue Cao; Diana Li; Zhou Shen; Daniel Normolle
Journal:  Acad Radiol       Date:  2010-04       Impact factor: 3.173

7.  A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung.

Authors:  Sarah M McGuire; Sumin Zhou; Lawrence B Marks; Mark Dewhirst; Fang-Fang Yin; Shiva K Das
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-01       Impact factor: 7.038

8.  Computed tomography assessment of response to therapy: tumor volume change measurement, truth data, and error.

Authors:  Michael F McNitt-Gray; Luc M Bidaut; Samuel G Armato; Charles R Meyer; Marios A Gavrielides; Charles Fenimore; Geoffrey McLennan; Nicholas Petrick; Binsheng Zhao; Anthony P Reeves; Reinhard Beichel; Hyun-Jung Grace Kim; Lisa Kinnard
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

9.  Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization.

Authors:  Shintaro Shirai; Morio Sato; Kazuhiro Suwa; Kazushi Kishi; Chigusa Shimono; Tetsuo Sonomura; Nobuyuki Kawai; Hirohiko Tanihata; Hiroki Minamiguchi; Motoki Nakai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-18       Impact factor: 7.038

10.  A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.

Authors:  Feng-Ming Spring Kong; Kirk A Frey; Leslie E Quint; Randall K Ten Haken; James A Hayman; Marc Kessler; Indrin J Chetty; Daniel Normolle; Avraham Eisbruch; Theodore S Lawrence
Journal:  J Clin Oncol       Date:  2007-07-20       Impact factor: 44.544

View more
  9 in total

1.  Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.

Authors:  Abdallah S R Mohamed; Carlos E Cardenas; Adam S Garden; Musaddiq J Awan; Crosby D Rock; Sarah A Westergaard; G Brandon Gunn; Abdelaziz M Belal; Ahmed G El-Gowily; Stephen Y Lai; David I Rosenthal; Clifton D Fuller; Michalis Aristophanous
Journal:  Radiother Oncol       Date:  2017-07-31       Impact factor: 6.280

2.  Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.

Authors:  Eunsin Lee; Jing Zeng; Robert S Miyaoka; Jatinder Saini; Paul E Kinahan; George A Sandison; Tony Wong; Hubert J Vesselle; Ramesh Rengan; Stephen R Bowen
Journal:  Med Phys       Date:  2017-06-01       Impact factor: 4.071

3.  A sparse orthogonal collimator for small animal intensity-modulated radiation therapy. Part II: hardware development and commissioning.

Authors:  Kaley Woods; Ryan Neph; Dan Nguyen; Ke Sheng
Journal:  Med Phys       Date:  2019-11-04       Impact factor: 4.071

4.  Oxygen consumption dynamics in steady-state tumour models.

Authors:  David Robert Grimes; Alexander G Fletcher; Mike Partridge
Journal:  R Soc Open Sci       Date:  2014-09-24       Impact factor: 2.963

5.  Priority-driven plan optimization in locally advanced lung patients based on perfusion SPECT imaging.

Authors:  Martha M Matuszak; Charles Matrosic; David Jarema; Daniel L McShan; Matthew H Stenmark; Dawn Owen; Shruti Jolly; Feng-Ming Spring Kong; Randall K Ten Haken
Journal:  Adv Radiat Oncol       Date:  2016-10-29

6.  Hyperpolarized 129Xe Magnetic Resonance Imaging for Functional Avoidance Treatment Planning in Thoracic Radiation Therapy: A Comparison of Ventilation- and Gas Exchange-Guided Treatment Plans.

Authors:  Leith J Rankine; Ziyi Wang; Chris R Kelsey; Elianna Bier; Bastiaan Driehuys; Lawrence B Marks; Shiva K Das
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-07-13       Impact factor: 7.038

7.  A method for estimating the oxygen consumption rate in multicellular tumour spheroids.

Authors:  David Robert Grimes; Catherine Kelly; Katarzyna Bloch; Mike Partridge
Journal:  J R Soc Interface       Date:  2014-01-15       Impact factor: 4.118

8.  Estimating oxygen distribution from vasculature in three-dimensional tumour tissue.

Authors:  David Robert Grimes; Pavitra Kannan; Daniel R Warren; Bostjan Markelc; Russell Bates; Ruth Muschel; Mike Partridge
Journal:  J R Soc Interface       Date:  2016-03       Impact factor: 4.118

9.  Impact of different biologically-adapted radiotherapy strategies on tumor control evaluated with a tumor response model.

Authors:  Araceli Gago-Arias; Beatriz Sánchez-Nieto; Ignacio Espinoza; Christian P Karger; Juan Pardo-Montero
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.